Phase II Trial of Arsenic Trioxide and Dose-Escalated Cholecalciferol in Myelodysplastic Syndrome.
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2017
At a glance
- Drugs Arsenic trioxide (Primary) ; Colecalciferol
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 12 Jul 2012 Actual end date (1 May 2010) added as reported by ClinicalTrials.gov.
- 01 May 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 13 Sep 2005 New trial record.